Glomerular filtration rate

被引：18

作者：

Clase, Catherine M. ^{[1
]}

机构：

[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 1Y2, Canada

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2006年 / 333卷 / 7577期

关键词：

D O I：

10.1136/bmj.39030.594259.BE

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1030 / 1031

页数：2

共 11 条

[1] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[2] Low protein diets for chronic kidney disease in non diabetic adults [J].

Fouque, D. ;

Laville, M. ;

Boissel, J. P. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02)

[3] Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey [J].

Hallan, Stein I. ;

Dahl, Ketil ;

Oien, Cecilia M. ;

Grootendorst, Diana C. ;

Aasberg, Arne ;

Holmen, Jostein ;

Dekker, Friedo W. .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7577) :1047-1050

[4] Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data [J].

Jafar, TH ;

Schmid, CH ;

Landa, M ;

Giatras, I ;

Toto, R ;

Remuzzi, G ;

Maschio, G ;

Brenner, BM ;

Kamper, A ;

Zucchelli, P ;

Becker, G ;

Himmelmann, A ;

Bannister, K ;

Landais, P ;

Shahinfar, S ;

de Jong, PE ;

de Zeeuw, D ;

Lau, J ;

Levey, AS .

ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) :73-87

[5] Unreferred chronic kidney disease: A longitudinal study [J].

John, R ;

Webb, M ;

Young, A ;

Stevens, PE .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (05) :825-835

[6] EFFECTS OF LABELING ON INCOME, WORK AND SOCIAL FUNCTION AMONG HYPERTENSIVE EMPLOYEES [J].

JOHNSTON, ME ;

GIBSON, ES ;

TERRY, CW ;

HAYNES, RB ;

TAYLOR, DW ;

GAFNI, A ;

SICURELLA, JI ;

SACKETT, DL .

JOURNAL OF CHRONIC DISEASES, 1984, 37 (06) :417-423

[7] National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification [J].

Levey, AS ;

Coresh, J ;

Balk, E ;

Kausz, AT ;

Levin, A ;

Steffes, MW ;

Hogg, RJ ;

Perrone, RD ;

Lau, J ;

Eknoyan, G .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (02) :137-147

[8] Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) [J].

Levey, AS ;

Eckardt, KU ;

Tsukamoto, Y ;

Levin, A ;

Coresh, J ;

Rossert, J ;

de Zeeuw, D ;

Hostetter, TH ;

Lameire, N ;

Eknoyan, G .

KIDNEY INTERNATIONAL, 2005, 67 (06) :2089-2100

[9] Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic - A report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) [J].

Rahman, M ;

Pressel, S ;

Davis, BR ;

Nwachuku, C ;

Wright, JT ;

Whelton, PK ;

Barzilay, J ;

Batuman, V ;

Eckfeldt, JH ;

Farber, M ;

Henriquez, M ;

Kopyt, N ;

Louis, GT ;

Saklayen, M ;

Stanford, C ;

Walworth, C ;

Ward, H ;

Wiegmann, T .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (08) :936-946

[10]

TAAL M, 2006, CLIN PRACTICE GUIDEL

← 1 2 →